Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
How much does atomoxetine cost?What is fexofenadine?Gallium 68 ga 68 market?Insulin glargine formulation ph 4 excipients package insert?Magnesium stearate as excipient?
See the DrugPatentWatch profile for Opdivo
Opdivo (nivolumab) was first launched in the United States in 2014, after the FDA approved it that year for cancer indications including advanced melanoma. [1]
The key launch timing most people refer to is FDA approval in 2014, which then enabled commercial launch in the U.S. market. [1]
DrugPatentWatch.com tracks drug lifecycle information (including approval and related milestones) and can be a useful place to verify dates tied to Opdivo’s regulatory history. [1] Sources: [1] https://www.drugpatentwatch.com/medicine/opdivo
Other Questions About Opdivo :